HIV感染中CD9+微囊泡大量释放,与病毒学控制无关
研究比较未治疗、治疗病毒学抑制、精英控制者、病毒学控制者及未感染对照共5组(每组30例)血浆微囊泡。所有HIV感染组微囊泡数量较对照扩大至少10倍,>79%为血小板来源;含线粒体微囊泡比例与线粒体密度低于对照,且与ccf-mtDNA相关。
要点
- HIV感染各组血浆微囊泡较对照扩大至少10倍,以血小板来源为主。
- 含线粒体微囊泡比例与线粒体密度在HIV感染中降低,ART组最低。
- 微囊泡数量与ccf-mtDNA水平相关,后者在HIV感染中更高。
核心结论
- HIV感染期间发生血小板来源微囊泡的大量释放,部分含线粒体但比例与密度低于对照。
研究设计与样本
- 五组各30例:ART初治、ART治疗病毒学不可测、精英控制者、病毒学控制者及HIV未感染对照,流式细胞术定量血浆微囊泡。
主要发现
- 所有HIV感染组微囊泡数量较对照扩大至少10倍,>79%为血小板来源。
- 含线粒体微囊泡比例22.3% vs 41.6%、线粒体密度706 vs 1346,HIV感染低于对照,ART组最低。
- 微囊泡数量与ccf-mtDNA水平相关,后者在HIV感染中更高。
临床怎么用
- 血小板来源微囊泡可能作为血小板活化生物标志物,或反映无HIV复制时的发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of extracellular vesicles (EVs) in human immunodeficiency virus (HIV) pathogenesis is unknown. We examine the cellular origin of plasma microvesicles (MVs), a type of ectocytosis-derived EV, the presence of mitochondria in MVs, and their relationship to circulating cell-free mitochondrial deoxyribonucleic acid (ccf-mtDNA) in HIV-infected patients and controls. METHODS: Five participant groups were defined: 30 antiretroviral therapy (ART)-naive; 30 ART-treated with nondetectable viremia; 30 elite controllers; 30 viremic controllers; and 30 HIV-uninfected controls. Microvesicles were quantified and characterized from plasma samples by flow cytometry. MitoTrackerDeepRed identified MVs containing mitochondria and ccf-mtDNA was quantified by real-time polymerase chain reaction. RESULTS: Microvesicle numbers were expanded at least 10-fold in all HIV-infected groups compared with controls. More than 79% were platelet-derived MVs. Proportions of MVs containing mitochondria (22.3% vs 41.6%) and MV mitochondrial density (706 vs 1346) were significantly lower among HIV-infected subjects than controls, lowest levels for those on ART. Microvesicle numbers correlated with ccf-mtDNA levels that were higher among HIV-infected patients. CONCLUSIONS: A massive release of platelet-derived MVs occurs during HIV infection. Some MVs contain mitochondria, but their proportion and mitochondrial densities were lower in HIV infection than in controls. Platelet-derived MVs may be biomarkers of platelet activation, possibly reflecting pathogenesis even in absence of HIV replication.
引用
- Poveda E, Tabernilla A, Fitzgerald W, et al. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control. J Infect Dis. 2022. PMID: 32603406. doi:10.1093/infdis/jiaa375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。